Piramal Pharma Ltd. - Research Center
543635 PPLPHARMA Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | ||
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 1,322.95 | 1,193.32 | 1,185.91 | 994.60 | |
| Share application money | - | - | - | 0.10 | |
| Preference share capital | - | - | - | - | |
| Reserves & surplus | 5,389.12 | 4,068.47 | 3,881.43 | 3,105.92 | |
| Loan funds | |||||
| Secured loans | 1,151.89 | 1,627.28 | 1,101.53 | 165.20 | |
| Unsecured loans | - | - | - | - | |
| Total | 7,863.96 | 6,889.07 | 6,168.87 | 4,265.82 | |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 3,409.38 | 3,263.22 | 2,123.42 | 2,064.23 | |
| Less : revaluation reserve | - | - | - | - | |
| Less : accumulated depreciation | 797.22 | 661.35 | 514.44 | 437.42 | |
| Net block | 2,612.16 | 2,601.87 | 1,608.98 | 1,626.81 | |
| Capital work-in-progress | 533.24 | 416.57 | 205.10 | 121.00 | |
| Investments | 1,708.16 | 1,746.99 | 2,634.29 | 1,591.52 | |
| Net current assets | |||||
| Current assets, loans & advances | 4,697.32 | 3,276.97 | 2,759.95 | 2,417.34 | |
| Less : current liabilities & provisions | 1,686.92 | 1,153.33 | 1,039.45 | 1,490.85 | |
| Total net current assets | 3,010.40 | 2,123.64 | 1,720.50 | 926.49 | |
| Miscellaneous expenses not written | - | - | - | - | |
| Total | 7,863.96 | 6,889.07 | 6,168.87 | 4,265.82 | |
| Notes: | |||||
| Book value of unquoted investments | 1,646.88 | 1,646.83 | 2,634.29 | 1,591.52 | |
| Market value of quoted investments | - | - | - | - | |
| Contingent liabilities | 190.29 | 150.70 | 101.97 | 75.22 | |
| Number of equity sharesoutstanding (Lacs) | 13229.48 | 11933.19 | 11859.14 | 9946.02 | |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis